Skip to content

The efficacy of coblation vs. bipolar radiofrequency inferior turbinate reduction in the management of nasal obstruction in OSA patients: A double-blinded randomized controlled trial

The efficacy of coblation vs. bipolar radiofrequency inferior turbinate reduction in the management of nasal obstruction in OSA patients: A double-blinded randomized controlled trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250107005
Enrollment
36
Registered
2025-01-07
Start date
2024-12-09
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasal obstruction in patients with obstructive sleep apnea (OSA) requiring continuous positive airway pressure (CPAP) ventilation. inferior turbinate reduction, radiofrequency abrasion, coblation, nasal obstruction, obstructive sleep apnea, continuous positive airway pressure ventilation

Interventions

Radio-frequency Inferior Turbinate Reduction with Bipolar RaVoRTM Needle Electrode with the CURIS 4 MHz radio-frequency generator, Sutter Medizintechnik GMBH, Freiburg, Germany,Radio-frequency Inferio
Active Comparator Device,Active Comparator Device
Bipolar Radio-frequency Inferior Turbinate Reduction,Coblation Inferior Turbinate Reduction

Sponsors

Department of Otolaryngology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Adult (Age 20-65 years) OSA patients 2. Using CPAP for at least 3 months 3. Had symptoms of nasal obstruction via Visual Analogue Scale Evaluation (VAS) of more than 5 4. Bilateral inferior turbinate hypertrophy of grades II to III via the Friedman grading system

Exclusion criteria

Exclusion criteria: 1. Patients with previous nasal or sinus surgery, septal deformity, nasal polyposis, sinusitis, and nasal cavity tumor 2. Patient with coagulopathy, cardiac pacemaker or other implanted electronic devices 3. Patient denial

Design outcomes

Primary

MeasureTime frame
Nasal obstruction symptom at 3 and 6 months after end of intervention Visual Analogue Scale Evaluation (VAS),Nasal cavity air flow at 3 and 6 months after end of intervention Peak Nasal Inspiratory Flow (PNIF)

Secondary

MeasureTime frame
Reduction of the Apnea-Hypopnea Index (AHI) and CPAP Pressure at 6 months after end of intervention Polysomnogram,CPAP compliance at 6 months after end of intervention CPAP report,Operation time Intrapoerative Operation Record,Complication at intraoperative, 2 weeks, 3 and 6 months after end of intervention Medical Record

Countries

Thailand

Contacts

Public ContactNawat Ungkhara

Faculty of Medicine Ramathibodi Hospital, Mahidol University

count-junior@hotmail.com0917746174

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026